Sanofi CEO Viehbacher Sees Return to Growth This Quarter

Sanofi Chief Executive Officer Chris Viehbacher said the French drugmaker will return to earnings growth in the fourth quarter after the loss of patent protection on nine drugs in the past three years eroded profit.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.